
Sign up to save your podcasts
Or
"Imagine a fast-spreading respiratory HIV. It sweeps around the world. Almost nobody has symptoms. Nobody notices until years later, when the first people who are infected begin to succumb. They might die, something else debilitating might happen to them, but by that point, just about everyone on the planet would have been infected already.
And then it would be a race. Can we come up with some way of defusing the thing? Can we come up with the equivalent of HIV antiretrovirals before it's too late?" — Kevin Esvelt
In today’s episode, host Luisa Rodriguez interviews Kevin Esvelt — a biologist at the MIT Media Lab and the inventor of CRISPR-based gene drive — about the threat posed by engineered bioweapons.
Links to learn more, summary and full transcript.
They cover:
Producer and editor: Keiran Harris
Audio Engineering Lead: Ben Cordell
Technical editing: Simon Monsour
Additional content editing: Katy Moore and Luisa Rodriguez
Transcriptions: Katy Moore
4.8
280280 ratings
"Imagine a fast-spreading respiratory HIV. It sweeps around the world. Almost nobody has symptoms. Nobody notices until years later, when the first people who are infected begin to succumb. They might die, something else debilitating might happen to them, but by that point, just about everyone on the planet would have been infected already.
And then it would be a race. Can we come up with some way of defusing the thing? Can we come up with the equivalent of HIV antiretrovirals before it's too late?" — Kevin Esvelt
In today’s episode, host Luisa Rodriguez interviews Kevin Esvelt — a biologist at the MIT Media Lab and the inventor of CRISPR-based gene drive — about the threat posed by engineered bioweapons.
Links to learn more, summary and full transcript.
They cover:
Producer and editor: Keiran Harris
Audio Engineering Lead: Ben Cordell
Technical editing: Simon Monsour
Additional content editing: Katy Moore and Luisa Rodriguez
Transcriptions: Katy Moore
4,212 Listeners
26,425 Listeners
2,391 Listeners
430 Listeners
120 Listeners
89 Listeners
349 Listeners
134 Listeners
123 Listeners
62 Listeners
63 Listeners
138 Listeners
63 Listeners
115 Listeners
89 Listeners